Skip to content
OpenCapital
Get started

Prestige Consumer Healthcare PBH Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

Organon logo
OrganonOGN
——
Viatris logo
ViatrisVTRS
——
Henry Schein logo
Henry ScheinHSIC
——

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S2×-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Prestige Consumer Healthcare (PBH) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $56.36 in Q4 2025.
How has Prestige Consumer Healthcare's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
Prestige Consumer Healthcare's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price increased by 10.3% year-over-year, from $51.1 to $56.36.
What is the long-term trend for Prestige Consumer Healthcare's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 4 years (2021 to 2025), Prestige Consumer Healthcare's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a 8.3% compound annual growth rate (CAGR), from $37.92 to $52.22.